Epenetos A A, Courtenay-Luck N, Pickering D, Hooker G, Durbin H, Lavender J P, McKenzie C G
Br Med J (Clin Res Ed). 1985 May 18;290(6480):1463-6. doi: 10.1136/bmj.290.6480.1463.
In a patient with recurrent grade IV glioma of the brain resistant to conventional treatment an antibody guided isotopic scan showed uptake by the tumour of a monoclonal antibody (9A) that was developed against epidermal growth factor receptor but cross reacted with blood group A antigen. As a therapeutic attempt antibody labelled with 1665 MBq (45.0 mCi) iodine-131 was delivered to the tumour area by infusion into the internal carotid artery. Computed tomography showed regression of the tumour after treatment, and an appreciable and sustained clinical improvement was noted without any toxicity. Delivery of irradiation guided by monoclonal antibody delivered by arterial infusion of the tumour area may be of clinical value in the treatment of brain gliomas resistant to conventional forms of treatment.
在一名对传统治疗耐药的复发性脑IV级胶质瘤患者中,抗体引导同位素扫描显示,一种针对表皮生长因子受体开发但与A血型抗原发生交叉反应的单克隆抗体(9A)在肿瘤部位摄取。作为一种治疗尝试,通过向颈内动脉输注将标记有1665MBq(45.0mCi)碘-131的抗体输送到肿瘤区域。计算机断层扫描显示治疗后肿瘤缩小,且观察到明显且持续的临床改善,无任何毒性。通过动脉输注肿瘤区域的单克隆抗体引导的辐射传递在治疗对传统治疗形式耐药的脑胶质瘤中可能具有临床价值。